All Curated Mutation Sites in HIV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All
  
IN
  
RT
  
LTR
  
CA
  
Gag
  
Nef
  
Env
  
gp120
  
gp160
  
gp41
  
gp140
  
MA
  
Pol
  
PR
  
Rev
  
Tat
  
Vpu
  
Vif
  
Vpr
  

Keyword: HIV Infections-21516199
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 21516199 A98G
RT
gag-pol
HIV Infections
D
G
C
L
T
View
2 21516199 D67D
RT
gag-pol
HIV Infections
D
G
C
L
T
View
3 21516199 D67N
RT
gag-pol
HIV Infections
D
G
C
L
T
View
4 21516199 E138E
RT
gag-pol
HIV Infections
D
G
C
L
T
View
5 21516199 E138K
RT
gag-pol
HIV Infections
D
G
C
L
T
View
6 21516199 E44A
RT
gag-pol
HIV Infections
D
G
C
L
T
View
7 21516199 E44D
RT
gag-pol
HIV Infections
D
G
C
L
T
View
8 21516199 E44E
RT
gag-pol
HIV Infections
D
G
C
L
T
View
9 21516199 E44K
RT
gag-pol
HIV Infections
D
G
C
L
T
View
10 21516199 G190A
RT
gag-pol
HIV Infections
D
G
C
L
T
View
11 21516199 G190G
RT
gag-pol
HIV Infections
D
G
C
L
T
View
12 21516199 K101E
RT
gag-pol
HIV Infections
D
G
C
L
T
View
13 21516199 K101K
RT
gag-pol
HIV Infections
D
G
C
L
T
View
14 21516199 K101Q
RT
gag-pol
HIV Infections
D
G
C
L
T
View
15 21516199 K103K
RT
gag-pol
HIV Infections
D
G
C
L
T
View
16 21516199 K103N
RT
gag-pol
HIV Infections
D
G
C
L
T
View
17 21516199 K103R
RT
gag-pol
HIV Infections
D
G
C
L
T
View
18 21516199 K219E
RT
gag-pol
HIV Infections
D
G
C
L
T
View
19 21516199 K219Q
RT
gag-pol
HIV Infections
D
G
C
L
T
View
20 21516199 K65R
RT
gag-pol
HIV Infections
D
G
C
L
T
View
21 21516199 K70E
RT
gag-pol
HIV Infections
D
G
C
L
T
View
22 21516199 K70K
RT
gag-pol
HIV Infections
D
G
C
L
T
View
23 21516199 K70R
RT
gag-pol
HIV Infections
D
G
C
L
T
View
24 21516199 L210W
RT
gag-pol
HIV Infections
D
G
C
L
T
View
25 21516199 L74V
RT
gag-pol
HIV Infections
D
G
C
L
T
View
26 21516199 M184I
RT
gag-pol
HIV Infections
D
G
C
L
T
View
27 21516199 M184M
RT
gag-pol
HIV Infections
D
G
C
L
T
View
28 21516199 M184V
RT
gag-pol
HIV Infections
D
G
C
L
T
View
29 21516199 M41L
RT
gag-pol
HIV Infections
D
G
C
L
T
View
30 21516199 M41M
RT
gag-pol
HIV Infections
D
G
C
L
T
View
31 21516199 Q151M
RT
gag-pol
HIV Infections
D
G
C
L
T
View
32 21516199 T215F
RT
gag-pol
HIV Infections
D
G
C
L
T
View
33 21516199 T215Y
RT
gag-pol
HIV Infections
D
G
C
L
T
View
34 21516199 T69D
RT
gag-pol
HIV Infections
D
G
C
L
T
View
35 21516199 T69N
RT
gag-pol
HIV Infections
D
G
C
L
T
View
36 21516199 V106M
RT
gag-pol
HIV Infections
D
G
C
L
T
View
37 21516199 V106V
RT
gag-pol
HIV Infections
D
G
C
L
T
View
38 21516199 V108I
RT
gag-pol
HIV Infections
D
G
C
L
T
View
39 21516199 V118I
RT
gag-pol
HIV Infections
D
G
C
L
T
View
40 21516199 V75M
RT
gag-pol
HIV Infections
D
G
C
L
T
View
41 21516199 V90I
RT
gag-pol
HIV Infections
D
G
C
L
T
View
42 21516199 Y181C
RT
gag-pol
HIV Infections
D
G
C
L
T
View
43 21516199 Y181I
RT
gag-pol
HIV Infections
D
G
C
L
T
View
44 21516199 Y181V
RT
gag-pol
HIV Infections
D
G
C
L
T
View
45 21516199 Y181Y
RT
gag-pol
HIV Infections
D
G
C
L
T
View
46 21516199 Y188L
RT
gag-pol
HIV Infections
D
G
C
L
T
View
Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.